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A B S T R A C T
Introduction: Even though ictal tachyarrhythmias are more common, ictal brady-asystole is more likely
to be fatal, and yet is potentially preventable with pacemaker (PM) implantation. We sought to quantify
the degree of association of PM placement in people with and without epilepsy, including neurological
and cardiovascular cohorts.
Methods: Retrospective cross-sectional analysis of the National Hospital Discharge database using
International Classiﬁcation of Diseases Clinical Modiﬁcation (ICD-9-CM) codes. We identiﬁed people
with and without epilepsy between 1990 and 2006. The epilepsy cohort was compared to patients
without epilepsy and other cardiovascular and central nervous system (CNS) disease cohorts.
Results: People with epilepsy had higher odds of temporary PM (TPM; OR 1.6) than patients without
epilepsy, especially amongst males (OR 2.0), young- (OR 4.6) and middle-aged (OR 4.3) patients. The
epilepsy cohort had signiﬁcantly higher odds of TPM than demyelinating disease (OR 7.9) and migraine
(OR 9.1) cohorts. Compared to stroke, people with epilepsy had higher odds of TPM in the male (OR 1.6)
and middle-age (OR 2.4) subgroups. No signiﬁcant association was seen with permanent PM (PPM).
Conclusions: Our study demonstrates the high likelihood of TPM placement in epilepsy patients as
compared to cohorts without epilepsy. Signiﬁcant associations were seen especially in males and young-
and middle-aged patients. Since demyelinating and migraine cohorts are somewhat similar to epilepsy
patients in age and sex characteristics, the higher odds of TPM in epilepsy patients may be related to the
disease mechanism causing brady-asystole; however this requires further study.
Published by Elsevier Ltd on behalf of British Epilepsy Association.
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Cardiac and hemodynamic abnormalities following brain
injury are not uncommon,1–4 but the exact mechanisms are
poorly understood.5 Some experimental and clinical observa-
tions have drawn attention to the insular cortex, which appears
to be a locus of autonomic and cardiac control.4,6–9 Cingulate
gyrus, amygdala and orbitofrontal cortices have also been
implicated in control of autonomic function.5,10–12 Any brain
injury, whether focal or diffuse, resulting from infection, trauma,
mass, ischemia, hemorrhage or seizures, has been linked to
cardiac dysfunction.1–3,13 Although the mechanism of a previ-
ously poorly understood phenomenon, sudden unexpected
death in epilepsy (SUDEP) is thought to be multifactorial,
inappropriate response of the autonomic nervous system,* Corresponding author at: Department of Neurology, UMDNJ/Cooper University
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http://dx.doi.org/10.1016/j.seizure.2012.05.007including intra-ictal bradyrhythmias is one of the presumed
culprits.6,7,14
While sinus tachycardia is the most common intra-ictal
arrhythmia, bradyarrhythmias and asystole are more likely to be
fatal, and yet are potentially preventable. There are no established
guidelines for treating and preventing ictal bradyarrhythmias, but
anecdotal reports of permanent pacemaker (PPM) placement have
shown beneﬁt in preventing sudden collapse and injury.15–17 To
date, the risk of PM placement in epilepsy patients has not been
studied. Thus, we sought to evaluate if epilepsy patients have
increased odds of PM placement as compared to patients in other
CNS and cardiovascular disease categories.
2. Methods
We performed a cross-sectional analysis of the National
Hospital Discharge Survey (NHDS), a database of discharges
from approximately 500 nonfederal short-term hospitals
throughout the 50 states. Data was reviewed from 1990 to
2006 using the International Classiﬁcation of Diseases Clinical
Modiﬁcation (ICD-9-CM) and procedure codes to identify the
number of discharges with and without epilepsy (345–345.9), Association.
Table 1
The odds of PM placement in epilepsy cohort vs. comparison groups. (Odds ratio (OR)>1=higher odds of PMwith epilepsy than comparison group,<1 epilepsy has lower odds, 1 =no difference). Bold highlights = epilepsy cohort has
higher odds of PM placement compared to the disease listed. C = combined PM (either PM), PPM=permanent PM, TPM= temporary PM.
Epilepsy vs.
non-epilepsy
Epilepsy vs.
inﬂammatory
diseases
Epilepsy vs.
hereditary/
degenerative
diseases
Epilepsy vs.
demyelinating
diseases
Epilepsy vs.
migraines
Epilepsy vs.
PNS disorders
Epilepsy vs.
stroke
Epilepsy vs.
acute/subacute
CAD
Epilepsy vs.
chronic CAD
PM 0.40 4.26 0.29 1.45 1.90 0.40 0.23 0.09 0.11
(0.39–0.42) (3.75–4.85) (0.28–0.30) (1.36–1.54) (1.79–2.01) (0.39–0.42) (0.22–0.24) (0.08–0.10) (0.10–0.12)
PPM 0.20 2.26 0.14 0.70 0.94 0.20 0.12 0.11 0.07
(0.19–0.22) (1.95–2.61) (0.13–0.14) (0.65–0.76) (0.87–1.08) (0.19–0.21) (0.11–0.13) (0.10–0.12) (0.06–0.08)
TPM 1.63 13.66 1.97 7.90 9.10 1.81 0.94 0.08 0.22
(1.55–1.70) (10.13–18.43) (1.86–2.08) (6.67–9.36) (7.93–10.43) (1.70–1.94) (0.90–0.99) (0.07–0.09) (0.21–0.23)
Male – PM 0.36 10.25 0.31 11.80 0.47 0.30 0.09 0.11
(0.34–0.37) (7.97–13.19) (0.30–0.33) (9.23–15.10) (0.44–0.49) (0.29–0.32) (0.09–0.10) (0.10–0.12)
Male – PPM 0.09 7.01 0.07 2.44 0.11 0.07 0.06 0.03
(0.08–0.10) (4.42–11.14) (0.06–0.08) (1.87–3.17) (0.10–0.12) (0.06–0.08) (0.05–0.07) (0.02–0.04)
Male – TPM 2.05 11.65 2.83 4.15 1.61 0.11 0.31
(1.94–2.16) (8.63–15.73) (2.64–3.03) (3.74–4.60) (1.51–1.70) (0.10–0.12) (0.30–0.33)
Female – PM 0.43 2.34 0.26 1.45 0.35 0.19 0.08 0.11
(0.41–0.45) (2.01–2.72) (0.250–0.28) (1.35–1.55) (0.33–0.37) (0.18–0.20) (0.07–0.09) (0.10–0.12)
Female – PPM 0.34 1.59 0.19 1.12 0.28 0.15 0.15 0.10
(0.32–0.36) (1.36–1.86) (0.18–0.21) (1.04–1.22) (0.26–0.30) (0.14–0.16) (0.14–0.16) (0.09–0.11)
Female – TPM 0.96 1.07 0.74 0.45 0.04 0.13
(0.88–1.06) (0.97–1.18) (0.67–0.83) (0.41–0.50) (0.03–0.05) (0.12–0.14)
<33 – PM 1.53 5.52 5.27 0.13 0.07 0.03
(1.38–1.70) (4.09–7.46) (3.91–7.10) (0.12–0.15) (0.06–0.09) (0.02–0.04)
<33 – PPM 0.58 1.58 1.50 0.04 0.04 0.04
(0.47–0.70) (1.12–2.22) (1.07–2.11) (0.03–0.05) (0.03–0.05) (0.03–0.05)
<33 – TPM 4.58 0.12 0.03
(4.05–5.18) (0.10–0.14) (0.02–0.03)
33–66 – PM 1.10 0.61 2.57 1.55 0.93 0.17 0.22
(1.04–1.15) (0.57–0.64) (2.39–2.77) (1.45–1.65) (0.88–0.98) (0.16–0.18) (0.21–0.23)
33–66 – PPM 0.32 0.15 0.75 0.41 0.31 0.22 0.09
(0.29–0.36) (0.14–0.17) (0.66–0.84) (0.37–0.46) (0.28–0.35) (0.20–0.24) (0.08–0.10)
33–66 – TPM 4.28 2.37 0.16 0.36
(4.03–4.53) (2.21–2.56) (0.15–0.17) (0.34–0.38)
67–99 – PM 0.36 0.62 0.55 0.45 0.19 0.24
(0.34–0.38) (0.58–0.65) (0.52–0.59) (0.43–0.48) (0.18–0.20) (0.22–0.25)
67–99 – PPM 0.30 0.48 0.73 0.46 0.37 0.33 0.22
(0.28–0.32) (0.45–0.52) (0.66–0.81) (0.43–0.50) (0.35–0.39) (0.31–0.35) (0.20–0.23)
67–99 – TPM 0.82 1.001 (1.001–1.001) 1.04 0.09 0.30
(0.74–0.91) (0.93–1.16) (0.080–0.10) (0.27–0.34)
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U. Akbar et al. / Seizure 21 (2012) 518–521520PPM (37.8–37.83, 0050–52) and temporary PM (TPM, 37.78), as
primary or secondary diagnoses. Prevalence odds ratios (OR) and
95% conﬁdence intervals (CI) were then calculated.
The OR of PM placement in epilepsy patients were compared to
other cardiac and CNS disease groups including: acute/subacute
coronary artery disease (CAD; 410, 411), chronic CAD (412, 414),
and stroke (430, 431, 433), inﬂammatory CNS disorders (320–325),
hereditary/degenerative disorders (330–337), demyelinating dis-
eases (340–341), migraines (346) and peripheral nervous system
(PNS) disorders (350–359). Both hemorrhagic and ischemic strokes
were included. Mantel–Haenszel test was used to analyze one
subgroup variable (age, sex) at a time. Age was divided into young
(<33 years), middle (34–66) and old (67–99). Data were selected
from a sub-sample, in which all subjects had one or more disease of
interest among the discharge orders. Analysis was not restricted to
primary diagnosis. Patients who had PM placement with multiple
diagnoses (i.e. epilepsy and migraines) were included under both
disease categories, as the indication for PM placement could not be
determined from the database. Since a de-identiﬁed, publicly
available database was utilized, institutional review was waived
by the board.
To validate the accuracy of ICD-9 codes for epilepsy and
pacemaker placement, medical records of random patients with
ICD-9 codes of 345–345.9, 37.8–37.83, 0050–52 and 37.78
admitted to our hospital were selected and reviewed. The positive
predictive value for these codes was 79%.
3. Results
A total of 547,853,302 patient records were analyzed including
2,213,657 admitted with a diagnosis of epilepsy (Table 1).
Compared to patients without epilepsy, the epilepsy cohort had
higher odds of TPM (OR 1.6) especially in males (OR 2.0) and
young- and middle-age patients (OR 4.6 and 4.3, respectively).
Compared to inﬂammatory diseases, epilepsy patients had higher
odds of PM, PPM and signiﬁcantly higher TPM placement,
especially in males. Compared to hereditary and degenerative
diseases, TPM was more likely in the general epilepsy population
(OR 2.0) and male patients with epilepsy in particular (OR 2.8).
Compared to demyelinating diseases, the epilepsy cohort had
higher odds of PM (OR 1.4), which can be expected as a result of the
signiﬁcantly higher odds of TPM placement (OR 7.9). A similar
relationship was seen in patients with migraine disorders (OR 9.1).
Compared to patients with stroke, male and middle-age patients
with epilepsy had higher odds of TPM (OR 1.6 and 2.4). The
epilepsy cohort did not have higher odds of either device
placement in any subgroup compared to coronary artery disease
cohorts.
4. Discussion
As cardiac and hemodynamic derangements may result from
excitation of various central autonomic centers,1,4,6,17–21 pace-
maker placement may theoretically prevent bradyarrhythmia-
related sudden death in epilepsy patients. We found that
compared to the general patient population, epilepsy patients
had higher odds of having a TPM, males more likely than females,
and young (<33) and middle (33–66) aged more likely than the
elderly (67–99). This general comparison, as well as the speciﬁc
comparisons made with other cohorts, reiterates that PM
placement is an age-dependent risk. No signiﬁcant association
with PPM was seen in comparison to the general patient
population, highlighting the transient and self-limited nature of
peri-ictal bradyarrhythmias. If these bradyarrhythmias were
persistent or recurrent, these patients would likely receive PPMs,
as many may have. Additionally, epilepsy patients had higherodds of PM placement than patients with migraine and
demyelinating diseases; two categories which are somewhat
comparable to epilepsy in age and sex demographics. This
relationship was signiﬁcantly stronger with the temporary
device. Furthermore, people with epilepsy had greater odds of
TPM placement than any other CNS disorder excluding stroke,
indicating that the mechanism of intracranial pathology, not just
the presence of such, is associated with bradyarrhythmias
requiring PM placement. Concomitant CAD prevalent in stroke
patients confounds the relationship of stroke and PM, since CAD
patients may be more likely to be implanted with a PM.
Nevertheless, males with epilepsy, as well as the 33–66 age
group, had higher odds of TPM than stroke patients.
Although previous studies have reported dysrhythmias associ-
ated with seizures and epilepsy,21–23 the risk of device-depen-
dence has not been studied at a large scale. After analyzing
electrocardiograms (EKGs) of 26 patients with temporal lobe
epilepsy, Blumhardt et al. found that 42% of patients had ictal
cardiac arrhythmias.23 Tachyarrhythmias occur more commonly
than bradyarrhythmias, perhaps because of the increased adren-
ergic output caused by the epileptic activity, as demonstrated in
animal studies.24 Occasionally, bradyarrhythmias are severe
enough to cause asystole and cardiac arrest. Several cases have
demonstrated ictal and peri-ictal bradycardia and asystole, some
requiring PPM placement.15,16,20 A larger cohort of 1244 patients
who underwent long-term video-EEG monitoring studied retro-
spectively showed that ﬁve patients (0.4%) had ictal asystole, with
11 asystolic events over a total of 19 seizures.21 All seizures were of
focal onset. Other large studies showed ictal asystole occurred in 2
of 589 patients (0.34%)25 and 10 of 2754 (0.27%).26 With refractory
focal epilepsies, 20 patients were implanted with loop recorders
and studied prospectively.27 Episodes of ictal-bradycardia and
asystole were recorded in 7 patients (35%) during an 18 months
mean observation period. Recently, among 6326 patients with
focal epilepsies studied, 16 patients (0.25%) had at least one brady-
asystolic event.28 7 patients were implanted with a PPM, 2
underwent surgery and all were continued on optimal antiepilep-
tic regimen. All patients with seizure-related falls and injuries who
were treated with a PPM became fall-free, even though some
continued to have seizures.
Bradyarrhthymias associated with epilepsy are known to be
transient, occurring in the peri-ictal period.27,28 Thus it is plausible
that some hospitalized patients would require a temporary
pacemaker but not a PPM. In fact, this may explain the signiﬁcant
differences between the epilepsy group and other cohorts studied.
Furthermore, much of our understanding of the role of cardiac
arrhythmias in SUDEP developed in the mid-to-late 1990s, and
signiﬁcant emphasis on spreading awareness had not occurred till
few years later. It is conceivable that lack of such data may have
resulted in implantation of temporary devices in the absence
of established literature indicating recurrence of peri-ictal
arrhythmias.21
Study limitations of note include reliance on the accuracy of
discharge diagnosis (ICD-9-CM) codes. Although mis-coding is
possible, it is unlikely to be a common occurrence among
thousands of physicians in several hundred hospitals. Our
validation of the code accuracy yielded an acceptable positive
predictive value. The lack of clinical data about epilepsy syndrome
classiﬁcation, degree of seizure control and antiepileptic regimen
in the epilepsy cohort precludes further analysis. These facts have
shown to be related to SUDEP.14 Additionally, due to the
retrospective nature of our study and the use of an administrative
database which is primarily compiled for billing purposes,
causality cannot be established. However, in comparison to other
CNS disorders with similar epidemiology, we found signiﬁcant
differences, especially in younger age groups.
U. Akbar et al. / Seizure 21 (2012) 518–521 5215. Conclusion
Our study provides valuable information to physicians and
patients in understanding the risk of bradyarrhythmias and
potential need for PM placement to prevent sudden falls. Epilepsy
was more likely associated with TPM placement compared to
people without epilepsy and cohorts of other CNS disorders. This
was especially true amongst young- and middle-aged patients.
Such association was not seen with PPM, attesting to the transient
nature of ictal brady-asystole. Due to lack of sufﬁcient evidence for
prophylactic PM placement to prevent recurrent falls, injuries and
potentially SUDEP,14 further research is needed to identify risk
factors for fatal bradyarrhythmias in epilepsy patients in whom
permanent device implantation may be considered.
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